We are live on
!
Find out more
Bessemer Group Portfolio holdings
AUM
$63.6B
1-Year Est. Return
28.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.59%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$14B
AUM Growth
+$1.63B
(+13%)
Cap. Flow
+$225M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
16.45%
Holding
1,448
New
199
Increased
366
Reduced
275
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$154M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$89.6M |
| 3 |
Lockheed Martin
LMT
|
+$86.9M |
| 4 |
BCM
iPath Pure Beta Broad Commodity ETN
BCM
|
+$76.4M |
| 5 |
iShares MSCI Japan ETF
EWJ
|
+$69.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$98.9M |
| 2 |
GE Aerospace
GE
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$92.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$67.4M |
| 5 |
Tapestry
TPR
|
+$60.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.01% |
| 2 | Technology | 14.16% |
| 3 | Financials | 12.66% |
| 4 | Industrials | 9.8% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
iShares Select Dividend ETF
DVY
$23.8B
| $362K | ﹤0.01% |
5,075
+3,100
| +157% | +$216K |
|
552
Canadian National Railway
CNI
$78.1B
| $352K | ﹤0.01% |
6,172
+6,102
| +8,717% | +$336K |
|
553
iShares Russell 2000 Growth ETF
IWO
$14.3B
| $352K | ﹤0.01% |
2,600
| – | – |
|
554
Republic Services
RSG
$67.5B
| $352K | ﹤0.01% |
10,558
| – | – |
|
|
TEG
555
DELISTED
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
| $352K | ﹤0.01% |
6,467
+3,594
| +125% | +$201K |
|
556
Devon Energy
DVN
$50.7B
| $350K | ﹤0.01% |
5,658
-3,735
| -40% | -$229K |
|
557
Ameren
AEE
$31.1B
| $346K | ﹤0.01% |
+9,580
| New | +$344K |
|
558
Core Laboratories
CLB
$521M
| $345K | ﹤0.01% |
1,803
+1
| +0.1% | +$186 |
|
|
BPL
559
DELISTED
Buckeye Partners, L.P.
BPL
| $342K | ﹤0.01% |
4,812
+1,900
| +65% | +$128K |
|
|
RAI
560
DELISTED
Reynolds American Inc
RAI
| $337K | ﹤0.01% |
13,498
+680
| +5% | +$17.2K |
|
561
Entergy
ETR
$53.5B
| $335K | ﹤0.01% |
10,634
+370
| +4% | +$11.8K |
|
562
Vanguard Mega Cap 300 Index ETF
MGC
$9.84B
| $332K | ﹤0.01% |
+5,250
| New | +$318K |
|
563
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $327K | ﹤0.01% |
4,100
| – | – |
|
564
Unilever
UL
$132B
| $324K | ﹤0.01% |
6,990
+890
| +15% | +$39.8K |
|
565
VanEck Agribusiness ETF
MOO
$985M
| $309K | ﹤0.01% |
+5,674
| New | +$301K |
|
|
PERF
566
DELISTED
Perfumania Holdings, Inc.
PERF
| $305K | ﹤0.01% |
+48,002
| New | +$234K |
|
567
Copa Holdings
CPA
$5.6B
| $302K | ﹤0.01% |
1,890
| – | – |
|
568
International Flavors & Fragrances
IFF
$19.6B
| $302K | ﹤0.01% |
3,509
| – | – |
|
|
UTIW
569
DELISTED
UTI WORLDWIDE INC
UTIW
| $301K | ﹤0.01% |
17,113
-902
| -5% | -$14.2K |
|
570
Coca-Cola Europacific Partners
CCEP
$47.8B
| $296K | ﹤0.01% |
6,695
| – | – |
|
|
P
571
DELISTED
Pandora Media Inc
P
| $295K | ﹤0.01% |
11,048
-2,400
| -18% | -$65.8K |
|
572
General Dynamics
GD
$105B
| $294K | ﹤0.01% |
3,075
+1,005
| +49% | +$89.8K |
|
573
America Movil
AMX
$78B
| $293K | ﹤0.01% |
12,562
-6,188
| -33% | -$135K |
|
574
M&T Bank
MTB
$36.1B
| $292K | ﹤0.01% |
2,509
-5,380
| -68% | -$611K |
|
575
Jefferies Financial Group
JEF
$12.8B
| $291K | ﹤0.01% |
11,477
| – | – |
|
Similar funds
Bessemer Group's Q4 2013 Portfolio in Review
As of Q4 2013, Bessemer Group held 1,448 positions worth $14B, up 13% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bessemer Group's Q4 2013 filing shows 199 new, 366 increased, 275 reduced and 98 closed positions. Its largest new stake was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M. The largest sale was Teva Pharmaceuticals, an estimated $98.9M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Bessemer Group's largest Q4 2013 buy was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M.
- Bessemer Group added most to Viatris in Q4 2013, an estimated $154M increase.
- Bessemer Group's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $98.9M.
- Bessemer Group fully exited Rayonier in Q4 2013, selling an estimated $33.4M.
- Bessemer Group's ten largest holdings make up 16% of its $14B portfolio in Q4 2013.
- Bessemer Group opened 199 new positions and closed 98 in Q4 2013.
- Bessemer Group's portfolio value rose 13% quarter-over-quarter to $14B.
Based on Bessemer Group's 13F filing for Q4 2013, filed 18 Feb 2014.